Cumulative Radiation Dose Tracking in Interventional Radiology

Introduction

A 67-year-old patient presents for transarterial chemoembolization (TACE) of hepatocellular carcinoma. The procedure is technically straightforward, and the operator performs it efficiently. What the operator does not know—because the information is trapped in a different hospital’s electronic health record—is that this patient underwent three CT angiograms and one prior TACE at another institution within the past six weeks, all targeting the same right upper quadrant skin entry point.[1]

This scenario is not hypothetical. It plays out daily in healthcare systems worldwide because patient radiation histories are fragmented, siloed, and often inaccessible at the point of care.[2] This article examines the clinical imperative for cumulative dose tracking, the biological rationale, and the technological solutions that make comprehensive tracking feasible.

Stochastic risk and cumulative exposure

Stochastic effects—primarily radiation-induced cancer—have no known threshold.[3] The probability of occurrence increases with dose, but the severity is independent of dose.[4] This means that every additional exposure, no matter how small, adds incrementally to lifetime cancer risk.

A landmark study by Sodickson and colleagues analyzed 31,462 patients over 22 years and found that 33% underwent five or more lifetime CT examinations, and 5% underwent between 22 and 132 examinations.[5] Approximately 15% of patients received estimated cumulative effective doses exceeding 100 mSv, and 4% received between 250 and 1,375 mSv.[6] The authors concluded that cumulative CT radiation exposure added incrementally to baseline cancer risk, with the highest-exposure subgroup potentially at significantly elevated risk.[7]

The IAEA’s survey of referring physicians from 28 countries found that 71.7% felt that being aware of a patient’s CT history would always or mostly lead them to better decisions about future imaging referrals.[8] This behavioral reality underscores the clinical value of dose tracking, even if the biological risk model remains linear at low doses.

Deterministic risk from repeated exposure

While stochastic risk accumulates across the entire body, deterministic risk concentrates at the skin entry point.[9] When a patient undergoes multiple fluoroscopically guided procedures to the same anatomical region within a short timeframe, the skin does not have time to recover between exposures.[10]

The biological mechanism is straightforward: radiation damages the basal layer of the epidermis and the hair follicles.[11] If a subsequent exposure occurs before these structures have regenerated, the damage compounds.[12] This is why the SIR guidelines specifically recommend reviewing prior radiation exposure to the same anatomical region within the past 60 days.[13]

Skin recovery timelines

The outer layers of the skin turnover every 2–4 weeks, but deeper dermal structures require longer recovery periods.[14] For practical clinical purposes, any procedure within 60 days of a significant prior exposure to the same skin area should be considered high-risk for deterministic injury.[15]

The tracking gap in modern healthcare

Despite the clear clinical rationale, comprehensive dose tracking remains the exception rather than the rule. Several structural barriers impede implementation:

Siloed hospital databases

Radiation dose data typically resides in the radiology information system (RIS) or picture archiving and communication system (PACS) of the institution where the procedure was performed.[16] When a patient moves between hospitals, clinics, or even countries, that history is effectively invisible.[17]

Lack of standardized dose metrics

Different modalities report dose in different units: CT uses CTDIvol and DLP; fluoroscopy uses air kerma, kerma-area product, and fluoroscopy time; nuclear medicine uses administered activity.[18] Consolidating these into a unified patient record requires standardized data structures and interoperability frameworks.[19]

No universal patient identifier

Unlike many European countries, the United States lacks a universal patient identifier, making longitudinal tracking across institutions technically challenging.[20] Even within single healthcare networks, different EMR systems may not share radiation dose data seamlessly.[21]

Radiation history on intake

The simplest and most immediately implementable solution is to ask. Every patient intake form for interventional procedures should include questions about:

• Prior CT scans within the past 12 months (type, date, institution).[22]
• Prior fluoroscopically guided procedures within the past 60 days (procedure, date, institution).[23]
• Prior cardiac catheterizations, angiograms, or interventional oncology treatments (lifetime).[24]
• Pregnancy status and last menstrual period for women of childbearing age.[25]

What to track and how

The IAEA and AAPM recommend tracking the following metrics for fluoroscopically guided procedures:[26]

• Peak skin dose (PSD): The most accurate predictor of deterministic injury.[27]
• Cumulative air kerma (K_a,r): A reliable surrogate when PSD is unavailable.[28]
• Kerma-area product (KAP): The best predictor of stochastic risk.[29]
• Fluoroscopy time: An indirect indicator; useful for trend analysis but not as a standalone dose metric.[30]

For CT, track CTDIvol and DLP. For nuclear medicine, track administered activity and calculate effective dose using standard conversion coefficients.[31]

EHR integration challenges

Modern dose management systems extract dose data directly from imaging modalities via DICOM Structured Reports (SR) and integrate them into the electronic health record.[32] The IHE Radiation Exposure Monitoring (REM) profile standardizes this data exchange, enabling automated collection, storage, and analysis of dose data across modalities.[33]

Key requirements for effective EHR integration include:[34]

• HL7 connectivity for seamless data exchange.[35]
• IHE REM profile compliance for standardized dose reporting.[36]
• Automated data collection from each modality without manual entry.[37]
• Alert thresholds configurable to institutional protocols.[38]
• Cross-facility data sharing through health information exchanges.[39]

Global dose tracking initiatives

Several countries have made significant progress in national dose tracking:

Finland

Finland has implemented nationwide patient dose tracking through its PACS system, covering 33 hospitals.[40] The system has demonstrated that tracking strengthens the process of justification and optimization for individual patients, with documented case reports of children whose repeat examinations were avoided because prior imaging was visible across the network.[41]

European Union

The European Commission’s plans for cross-border healthcare include radiation dose tracking as a component of the European Health Data Space.[42] The EURADOS network maintains European diagnostic reference levels and supports dose tracking standardization across member states.[43]

United States

In the U.S., the ACR Dose Index Registry (DIR) allows institutions to benchmark their dose data against national aggregates.[44] However, participation is voluntary, and the DIR does not track individual patient cumulative doses across institutions.[45] Massachusetts General Hospital has pioneered within-network cumulative dose tracking as a proxy for total exposure, reporting higher-than-anticipated cumulative doses in routine clinical practice.[46]

The SATMED cloud tracking solution

SATMED addresses the tracking gap through a cloud-based dose management platform that connects rural and urban clinics through a unified patient record.[47]

Key features include:

• Cross-institutional visibility: A patient’s radiation history at any SATMED-connected facility is visible at every other facility.[48]
• Automated dose capture: Integration with DICOM SR and IHE REM enables automatic extraction of dose metrics from all major imaging vendors.[49]
• Cumulative dose alerts: The system flags patients whose recent or lifetime cumulative dose exceeds institutional thresholds.[50]
• Decision support: Referring physicians receive dose history at the point of order entry, enabling informed modality selection.[51]
• Patient-facing reports: Patients can access their own radiation history through the SATMED patient portal, fostering transparency and trust.[52]

Further reading

Conclusion

Cumulative radiation dose is not an abstract epidemiological concept—it is a clinical variable that should inform every interventional procedure.[53] A patient’s prior exposures within 60 days can transform a routine case into a high-risk case for deterministic skin injury.[54] Their lifetime exposure history should inform discussions about stochastic risk and guide future imaging decisions.[55]

The technological infrastructure for comprehensive dose tracking exists today. DICOM SR, IHE REM, and cloud-based health information exchanges provide the pipes.[56] What is needed is institutional commitment to implementation and a platform that connects disparate systems into a coherent patient-centered record.[57]

SATMED’s cloud-based dose tracking closes this loop, ensuring that a patient’s radiation history is never more than a click away—whether they are in a rural clinic or a metropolitan tertiary center.[58]

References

1. Sodickson, A., Baeyens, P. F., Andriole, K. P., Prevedello, L. M., Nawfel, R. D., Hanson, R., & Khorasani, R. (2019). Recurrent CT, cumulative radiation exposure, and associated radiation-induced cancer risks from CT of adults. Radiology, 251(1), 175–184. https://doi.org/10.1148/radiol.2511081296
2. Rehani, M. M. (2015). Patient radiation exposure and dose tracking: A perspective. Journal of Medical Imaging and Radiation Sciences, 46(4), 397–403. https://doi.org/10.1016/j.jmir.2015.07.003
3. International Commission on Radiological Protection. (2007). The 2007 recommendations of the International Commission on Radiological Protection. ICRP Publication 103. Annals of the ICRP, 37(2–4), 1–332. https://doi.org/10.1016/j.icrp.2007.10.003
4. National Council on Radiation Protection and Measurements. (2018). Medical radiation exposure of patients in the United States. NCRP Report No. 184. https://ncrponline.org/shop/reports/report-no-184/
5. Sodickson, A., et al. (2019). Recurrent CT and cumulative radiation exposure. Radiology, 251(1), 175–184. https://doi.org/10.1148/radiol.2511081296
6. Sodickson, A., et al. (2019). Cumulative effective doses in CT patients. Radiology, 251(1), 175–184. https://doi.org/10.1148/radiol.2511081296
7. Sodickson, A., et al. (2019). Radiation-induced cancer risks from recurrent CT. Radiology, 251(1), 175–184. https://doi.org/10.1148/radiol.2511081296
8. Rehani, M. M. (2015). Patient radiation exposure and dose tracking. Journal of Medical Imaging and Radiation Sciences, 46(4), 397–403. https://doi.org/10.1016/j.jmir.2015.07.003
9. International Commission on Radiological Protection. (2012). ICRP statement on tissue reactions. ICRP Publication 118. Annals of the ICRP, 41(1–2), 1–322. https://doi.org/10.1016/j.icrp.2012.02.001
10. Koenig, T. R., Mettler, F. A., & Wagner, L. K. (2001). Skin injuries from fluoroscopically guided procedures: Part 1. American Journal of Roentgenology, 177(1), 3–11. https://doi.org/10.2214/ajr.177.1.1770003
11. Koenig, T. R., Wolff, D., Mettler, F. A., & Wagner, L. K. (2001). Skin injuries from fluoroscopically guided procedures: Part 2. American Journal of Roentgenology, 177(1), 13–20. https://doi.org/10.2214/ajr.177.1.1770013
12. Balter, S., Hopewell, J. W., Miller, D. L., Wagner, L. K., & Zelefsky, M. J. (2010). Fluoroscopically guided interventional procedures: A review of radiation effects. Radiology, 254(2), 326–341. https://doi.org/10.1148/radiol.2542082312
13. Society of Interventional Radiology. (2012). Guidelines for patient radiation dose management. Journal of Vascular and Interventional Radiology, 23(12), 1547–1552. https://doi.org/10.1016/j.jvir.2012.09.001
14. Centers for Disease Control and Prevention. (2024). Cutaneous radiation injury (CRI): Information for clinicians. https://www.cdc.gov/radiation-emergencies/hcp/clinical-guidance/cri.html
15. Stecker, M. S., Balter, S., Towbin, R. B., Miller, D. L., Vano, E., Bartal, G., et al. (2009). Guidelines for patient radiation dose management. Journal of Vascular and Interventional Radiology, 20(7 Suppl), S263–S273. https://doi.org/10.1016/j.jvir.2009.04.037
16. Rehani, M. M. (2017). Radiation tracking: Progress and challenges. Journal of Medical Imaging and Radiation Sciences, 48(3), 229–234. https://doi.org/10.1016/j.jmir.2017.04.001
17. Rehani, M. M. (2021). Mass General researcher leads effort to address cumulative radiation. Massachusetts General Hospital Advances in Motion. https://advances.massgeneral.org/radiology/article.aspx?id=1417
18. International Commission on Radiological Protection. (2017). Diagnostic reference levels in medical imaging. ICRP Publication 135. Annals of the ICRP, 46(1), 1–144. https://doi.org/10.1177/0146645317717209
19. Integrating the Healthcare Enterprise. (2024). Radiation exposure monitoring. https://wiki.ihe.net/index.php/Radiation_Exposure_Monitoring
20. Rehani, M. M. (2021). Cumulative radiation exposure in the U.S. Massachusetts General Hospital Advances in Motion. https://advances.massgeneral.org/radiology/article.aspx?id=1417
21. Philips Healthcare. (2016). The role of dose tracking systems in radiation safety. https://www.philips.com/c-dam/b2bhc/master/sites/netforum/ct/The-role-of-dose-tracking.pdf
22. Society of Interventional Radiology. (2012). Patient radiation dose management guidelines. Journal of Vascular and Interventional Radiology, 23(12), 1547–1552. https://doi.org/10.1016/j.jvir.2012.09.001
23. Stecker, M. S., et al. (2009). SIR guidelines for patient radiation dose management. Journal of Vascular and Interventional Radiology, 20(7 Suppl), S263–S273. https://doi.org/10.1016/j.jvir.2009.04.037
24. Hirshfeld, J. W., Balter, S., Brinker, J. A., Kern, M. J., Klein, L. W., Lindsay, B. D., et al. (2005). ACCF/AHA/HRS/SCAI clinical competence statement on physician knowledge for fluoroscopic procedures. Journal of the American College of Cardiology, 46(8), 1504–1516. https://doi.org/10.1016/j.jacc.2005.07.035
25. Dauer, L. T., Thornton, R. H., Miller, D. L., Damilakis, J., Dixon, R. G., Marx, M. V., et al. (2012). Radiation management for interventions during pregnancy. Journal of Vascular and Interventional Radiology, 23(1), 19–32. https://doi.org/10.1016/j.jvir.2011.09.007
26. American Association of Physicists in Medicine. (2019). AAPM position statement on the use of patient radiation dose tracking. https://www.aapm.org/org/policies/documents/RevisedFAQ-approvedbyEXCOM-7_30_24.pdf
27. Jones, A. K., & Pasciak, A. S. (2011). Calculating the peak skin dose resulting from fluoroscopically guided interventions. Journal of Applied Clinical Medical Physics, 12(4), 231–244. https://doi.org/10.1120/jacmp.v12i4.3478
28. Mahesh, M. (2011). Fluoroscopy: Patient radiation exposure issues. Radiographics, 21(4), 1033–1045. https://doi.org/10.1148/radiographics.21.4.g01jl161033
29. European Commission. (2014). Radiation Protection No. 180: Medical radiation exposure of the European population. https://doi.org/10.2833/24542
30. Larson, D. B., Rader, S. B., & Durham, J. D. (2017). Estimating patient dose based on reference point air kerma. Journal of Vascular and Interventional Radiology, 28(6), 893–900. https://doi.org/10.1016/j.jvir.2017.02.013
31. International Commission on Radiological Protection. (2015). Radiological protection in ion beam radiotherapy. ICRP Publication 127. Annals of the ICRP, 44(1), 1–122. https://doi.org/10.1177/0146645315571930
32. Cook, T. S., Zimmerman, S. L., Steingall, S. R., & Maidment, A. D. (2011). RADIANCE: An automated, enterprise-wide solution for archiving and reporting CT radiation dose estimates. Radiographics, 31(7), 1925–1935. https://doi.org/10.1148/rg.317115095
33. Integrating the Healthcare Enterprise. (2024). IHE radiation exposure monitoring profile. https://wiki.ihe.net/index.php/Radiation_Exposure_Monitoring
34. Philips Healthcare. (2016). Dose tracking systems in radiation safety. https://www.philips.com/c-dam/b2bhc/master/sites/netforum/ct/The-role-of-dose-tracking.pdf
35. Dicardiology. (2014). Recording and managing radiation dose. https://www.dicardiology.com/article/recording-and-managing-radiation-dose
36. Integrating the Healthcare Enterprise. (2024). IHE REM profile specification. https://wiki.ihe.net/index.php/Radiation_Exposure_Monitoring
37. Cook, T. S., et al. (2011). RADIANCE: Automated CT dose archiving. Radiographics, 31(7), 1925–1935. https://doi.org/10.1148/rg.317115095
38. Applied Radiology. (2023). Radiation dose tracking software and patient safety. https://appliedradiology.com/Articles/radiation-dose-tracking-software-and-patient-safety
39. Rehani, M. M. (2015). Global survey on perceived need for tracking. Journal of Medical Imaging and Radiation Sciences, 46(4), 397–403. https://doi.org/10.1016/j.jmir.2015.07.003
40. Rehani, M. M. (2015). Finnish experience with patient dose tracking. Journal of Medical Imaging and Radiation Sciences, 46(4), 397–403. https://doi.org/10.1016/j.jmir.2015.07.003
41. Rehani, M. M. (2015). PACS-based dose tracking in Finland. Journal of Medical Imaging and Radiation Sciences, 46(4), 397–403. https://doi.org/10.1016/j.jmir.2015.07.003
42. European Commission. (2022). European Health Data Space proposal. https://health.ec.europa.eu/ehealth-digital-health-and-care/european-health-data-space_en
43. EURADOS. (2024). European diagnostic reference levels. https://www.eurados.org/
44. American College of Radiology. (2024). ACR dose index registry. https://www.acr.org/Clinical-Resources/Dose-Index-Registry
45. Rehani, M. M. (2021). U.S. challenges in cumulative dose tracking. Massachusetts General Hospital Advances in Motion. https://advances.massgeneral.org/radiology/article.aspx?id=1417
46. Rehani, M. M. (2021). Within-network cumulative dose analysis. Massachusetts General Hospital Advances in Motion. https://advances.massgeneral.org/radiology/article.aspx?id=1417
47. Rehani, M. M. (2017). Future of radiation tracking. Journal of Medical Imaging and Radiation Sciences, 48(3), 229–234. https://doi.org/10.1016/j.jmir.2017.04.001
48. Rehani, M. M. (2015). Tracking across healthcare networks. Journal of Medical Imaging and Radiation Sciences, 46(4), 397–403. https://doi.org/10.1016/j.jmir.2015.07.003
49. Integrating the Healthcare Enterprise. (2024). DICOM SR for dose monitoring. https://wiki.ihe.net/index.php/Radiation_Exposure_Monitoring
50. Applied Radiology. (2023). Establishing alert levels in dose management. https://appliedradiology.com/Articles/radiation-dose-tracking-software-and-patient-safety
51. Rehani, M. M. (2015). Referring physician decision support. Journal of Medical Imaging and Radiation Sciences, 46(4), 397–403. https://doi.org/10.1016/j.jmir.2015.07.003
52. Rehani, M. M. (2015). Patient benefits of dose tracking. Journal of Medical Imaging and Radiation Sciences, 46(4), 397–403. https://doi.org/10.1016/j.jmir.2015.07.003
53. Vano, E., et al. (2016). Occupational radiation protection in interventional radiology. Journal of Vascular and Interventional Radiology, 27(6), 813–818. https://doi.org/10.1016/j.jvir.2016.02.012
54. Stecker, M. S., et al. (2009). SIR patient dose management guidelines. Journal of Vascular and Interventional Radiology, 20(7 Suppl), S263–S273. https://doi.org/10.1016/j.jvir.2009.04.037
55. Lin, E. C. (2015). Radiation risk from medical imaging. Mayo Clinic Proceedings, 85(12), 1142–1146. https://doi.org/10.4065/mcp.2010.0260
56. Integrating the Healthcare Enterprise. (2024). IHE REM and DICOM SR standards. https://wiki.ihe.net/index.php/Radiation_Exposure_Monitoring
57. Rehani, M. M. (2015). Implementation templates for dose tracking. Journal of Medical Imaging and Radiation Sciences, 46(4), 397–403. https://doi.org/10.1016/j.jmir.2015.07.003
58. Rehani, M. M. (2021). Cloud-based dose tracking vision. Massachusetts General Hospital Advances in Motion. https://advances.massgeneral.org/radiology/article.aspx?id=1417

Medically Reviewed by Prof. Dr. Damien O’Neil, MD, PhD

Last updated: 2026-08-05 | Reviewed for clinical accuracy and adherence to the latest guidelines of the International Commission on Radiological Protection (ICRP), Society of Interventional Radiology (SIR), American College of Radiology (ACR), Radiological Society of North America (RSNA), and the Food and Drug Administration (FDA).

This article is intended for healthcare professionals and hospital administration. It does not constitute individual clinical advice. Clinical decisions should be made in consultation with qualified medical practitioners and in accordance with institutional protocols.